Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Phase III Randomized Trial of Conventionally Fractionated vs. Hypofractionated COMprehensive Nodal Irradiation for Breast Cancer Using Pencil Beam Scanning PROton Therapy (COMPRO)

NCT05856773 is registered in ClinicalTrials.gov with Proton Collaborative Group as lead sponsor.

NCT NCT05856773
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT05856773 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Phase III Randomized Trial of Conventionally Fractionated vs. Hypofractionated COMprehensive Nodal Irradiation for Breast Cancer Using Pencil Beam Scanning PROton Therapy (COMPRO)
Lead sponsor
Proton Collaborative Group
Phase
Phase 3
Overall status
Recruiting
Start date
March 21, 2024
Completion date
February 28, 2041
Enrollment
276 (estimated)
Sites
9

Conditions

As the registry lists them; a condition with its own page is linked.

breast cancer